Download now: https://ow.ly/oAkW50SkgH3 Traditional #oncology marketing-oriented journeys neglect the increasing complexities and advancing technologies and treatments in the market. EVERSANA INTOUCH’s pioneering Tumor Journey Model considers all decision points, tumor characteristics and interactions to enable more effective marketing interventions.
About us
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
- Website
-
http://eversana.com
External link for EVERSANA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Specialties
- Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies
Locations
Employees at EVERSANA
Updates
-
Learn More: https://lnkd.in/gqCHQkd9 Join Jim Lang, CEO of EVERSANA, as we co-host Frontiers Health 2024! Don’t miss out—use code FH24EVS20 for 20% off your tickets! #FH24 #healthinnovation #futurehealth #innovation #healthcare #lifesciences
-
Read the blog: https://ow.ly/CQpx50Sw2Ww Check out the latest AMCP Dossier Format Version 5.0. Learn about health disparities, real-world evidence, digital therapeutics, and more. Authors: Joshua Gauci, Irene Zahirovic (Zelner), PhD, Deepika Thakur #AMCP #HealthDisparities #RWE #DigitalTheraeutics
-
ICYMI: https://lnkd.in/gy5JXQzt Pharma is evolving, and Medical Affairs is leading the charge! Pierantonio Russo MD, FCPP, FAAP, STS, explores the transformative impact of Medical Affairs on drug commercialization. Read on for more on these emerging priorities and technologies. #PharmaTransformation #MedicalAffairs
-
Read More: https://lnkd.in/gqCHQkd9 We’re thrilled to announce that EVERSANA is the presenting sponsor of Frontiers Health 2024! Join us in #Berlin this October to connect with leading innovators and explore the future of healthcare. Get 20% off your tickets with code FH24EVS20! #FH24 #healthinnovation #futurehealth #innovation #healthcare #lifesciences
-
Read the article: https://ow.ly/Z4Q150SkgQ9 Personalized #immunotherapies are the next frontier in the fight against #cancer. The one-patient, one-medicine model presents new hurdles for manufacturers to overcome and requires unique strategies. Download the article to understand the market drivers, complexities and opportunities in the #oncology space.
-
Read Now: https://lnkd.in/gJaC_vzt The race for rapid drug approvals in #oncology brings both opportunities and challenges. EVERSANA’s Anne Marie Robertson and Maneesh Gupta delve into the complexities of accelerated approvals and the critical need for robust commercial infrastructure in pharmaphorum’s latest Deep Dive Magazine. #Pharma #HealthcareInnovation #Commercialization
-
Read The Evidence Base® blog: https://lnkd.in/ecmiWJY3 EVERSANA's Tim Disher dives into the fascinating world of statistical methodology in #HEOR.
Crunching the numbers – statistical methodology tips in #HEOR In his regular column, Tim Disher, Senior Director of Biostatistics at EVERSANA, delves into the capabilities of #LargeLanguageModels for textual data analysis. For all you #Swifties, here Tim showcases the potential of #LLMs by conducting a thematic analysis of Taylor Swift’s, “The Tortured Poets Department.” Read at The Evidence Base® #healtheconomics #outcomesresearch #rwe #rwd #realworldevidence #realworlddata #marketaccess #pharma #biopharma #medicalaffairs #regulation #regulatoryaffairs #hta #healthtechnologyassessment #healthdata #healthequity #healthpolicy #AI #artificialintelligence
-
Watch the full recording: https://lnkd.in/gQistu8y Missed our live M&A and BD&L webinar? No worries! Catch the full recording now and gain insights into strategic commercial due diligence (CDD) and how its nature and role are changing in our current environment. Learn CCD impacts clinical, access and regulatory strategies. #MandA #BDL #CommercialDueDiligence #IndustryInsights #Webinar James Stephanou, Calvin Fujimoto-Cassidy, Jeremy Snook, Faruk Abdullah, Andrew Therrien, Andrew Ying, CFA, MPH, Justin Averback, Kevin Yin, Srinivas Tapa, PhD, MBA, Xavier Aparicio
-
Download the article: https://ow.ly/hoWR50SqYza AI is revolutionizing the HEOR landscape! Our latest article, authored by Chris Cameron and Tim Disher, explores how ChatGPT-4o and multi-AI agents are transforming the pace of HEOR insights and decision-making. Don’t miss out on this seismic shift! #AI #HEOR #ChatGPT4o #FutureOfHEOR